๐๐ ๐: 70 years old ๐๐๐ ๐ฅ๐๐ฏ๐๐ฅ: 15 ng/ml, rising kinetic ๐๐๐: Adenoma grade III mpRMI 2 years before PI-RADS 4 in left-lateralized base, biopsy (-) "๐๐ฉ๐ฆ ๐ด๐ข๐ฎ๐ฆ ๐ข๐จ๐จ๐ณ๐ฆ๐ด๐ด๐ช๐ท๐ฆ ๐ญ๐ฆ๐ด๐ช๐ฐ๐ฏ ๐ต๐ฉ๐ข๐ต ๐ธ๐ฆ ๐ด๐ข๐ธ (๐ข๐ฏ๐ฅ ๐ฎ๐ข๐ต๐ค๐ฉ๐ฆ๐ฅ ๐ธ๐ช๐ต๐ฉ ๐๐-๐๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ) ๐ธ๐ข๐ด ๐ต๐ฉ๐ฆ ๐ฐ๐ฏ๐ฆ ๐ต๐ฉ๐ข๐ต ๐ด๐ฉ๐ฐ๐ธ๐ฆ๐ฅ ๐ต๐ฉ๐ฆ ๐ฎ๐ฐ๐ด๐ต ๐ถ๐ฑ๐ต๐ข๐ฌ๐ฆ, ๐ข๐ฏ๐ฅ ๐ช๐ต ๐ธ๐ข๐ด ๐ข๐ญ๐ด๐ฐ ๐ข ๐ญ๐ฐ๐ค๐ข๐ญ๐ช๐ป๐ฆ๐ฅ ๐ต๐ถ๐ฎ๐ฐ๐ณ ๐ต๐ฉ๐ข๐ต ๐ฐ๐ฏ๐ญ๐บ ๐ฉ๐ข๐ฅ ๐ต๐ฉ๐ฆ ๐ฑ๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ ๐ญ๐ฆ๐ด๐ช๐ฐ๐ฏ ๐ข๐ฏ๐ฅ ๐ฏ๐ฐ๐ต๐ฉ๐ช๐ฏ๐จ ๐ฆ๐ญ๐ด๐ฆ ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ฐ๐ท๐ฆ๐ณ๐ข๐ญ๐ญ ๐ด๐ต๐ข๐จ๐ช๐ฏ๐จ ๐ฐ๐ง ๐ต๐ฉ๐ฆ ๐ฑ๐ข๐ต๐ช๐ฆ๐ฏ๐ต" - Dr. Margarita Garcรญa Fontes. โถ Watch the full webinar here: https://bit.ly/3wSrNfo
Lung cancer remains one of the most challenging cancers, and early detection is crucial for effective treatment. ๐ค As a contribution to #WorldLungCancerDay, and because each study brings us one step closer to better #patientcare, we wanted to share our latest research, led by Almudena Fuster Matanzo and Alfonso Picรณ. ๐ This comprehensive meta-analysis explores the potential of artificial intelligence in classifying tumor genetic profiles through CT scans. Our review encompasses 89 models, analyzing data from 32,084 non-small cell lung cancer (NSCLC) patients. The findings demonstrate promising correlations between imaging and genetic features. ๐ Read the full study: https://lnkd.in/ei66kFNe #LungCancer #CancerResearch
Lots of exciting news and inspiring conversations have happened in July: ๐ฆ๐บ QP-Prostate is now approved, available, and ready for use in Australia. ๐ฅ The Servicio de Radiologรญa Hospital Universitario Ramรณn y Cajal has recently adopted QP-Prostate to enhance diagnostic protocols for #prostatecancer. ๐ A new case study on โPredicting survival, neurotoxicity, and response in B-Cell lymphoma patients treated with CAR-T therapy using an imaging features-based modelโ is now available on our website. Stay updated on the latest advancements in #patientcare, #medicalimaging, and #radiology in this newest edition of our monthly newsletter:
QP-Prostate is the leading AI solution to improve prostate cancer detection. Need proof? Book a demo! https://lnkd.in/d-MVjMiV
๐ฆ๐บ QP-Prostateยฎ CAD has been officially approved for use in Australia! We are really proud to announce that, as of today, Quibim's #QPProstate technology can be used by Australian physicians for #AI-driven lesion detection thanks to algorithms trained with post-biopsy pathology data as ground truth. To find out more, contact us! https://lnkd.in/d-MVjMiV
According to the National Cancer Institute (NCI) in the United States, an estimated 71,100 people will be diagnosed with some form of head and neck cancer in 2024 in the US. Unfortunately, about 16,110 people will die from these diseases. #EarlyDetection is crucial in the fight against these cancers, and #AI is playing an increasingly vital role in this endeavor. ๐ In this context, on the World Head and Neck Cancer Day, we highlight a captivating conversation with Dr. Gema Bruixola, head and neck #oncologist. Read more about this insightful conversation: https://bit.ly/3wZgDp4 #WorldHeadandNeckCancerDay #AIinHealthcare #MedicalImaging #CancerResearch
With millions of new cases diagnosed annually, #ProstateCancer continues to be a significant global health challenge. The #FLUTEproject is changing the game by refining predictions of aggressive prostate cancer, aiming to reduce unnecessary biopsies and alleviate the physical and emotional burden on patients. By integrating QP-Prostateยฎ, the FLUTE Project - AI & Prostate Cancer enhances the accuracy of prostate cancer diagnostics. Early data shows promising results, with a marked decrease in invasive procedures and with more precise, targeted treatments. Read here more โฌ about the impact of this project on prostate cancer treatment.
๐ง Incredible advances have guided a new era of brain research, in which technology could radically transform our ability to image human brain tissue. Three-dimensional microscopy, tissue expansion and advanced computational techniques are enabling researchers to explore the complexities of the brain at the macroscopic and microscopic levels with unprecedented accuracy and speed. The impact of this sophisticated imaging system is significant, extending beyond academic research to critical clinical applications. Collaboration between academic progress and specialized imaging products such as QP-Brain could be transformative for researchers and #healthcare professionals seeking precision in neuroimaging. On #WorldBrainDay, we celebrate what connections between innovative research and clinical practice are achieving to advance the boundaries of what's possible in medical science and #patientcare. #BrainResearch #HealthTechnology
๐ฃ๏ธ In his talk at hashtag#ECR2024, David Bazaga, Product Lead at Quibim, highlighted critical challenges and innovative solutions in #ProstateCancer diagnosis. Here's a glimpse of David's presentation: "PSA testing has suboptimal sensitivity and specificity, often leading to unnecessary referrals for MRI and missed cancer diagnoses. Our QP-Prostate solution is designed to address these bottlenecks by providing fully automated lesion detection for clinically significant prostate cancer, improving diagnostic accuracy and efficiency." Are you curious to learn more about how QP-Prostate is transforming prostate cancer diagnosis? ๐ฒ Watch the full video presentation here: https://bit.ly/3Wr21ZB #AIinHealthcare #MedicalImaging #Radiology #Innovation #QPProstate
Want to know more about Quibim? Subscribe to our ๐๐ถ๐ป๐ธ๐ฒ๐ฑ๐๐ป ๐ป๐ฒ๐๐๐น๐ฒ๐๐๐ฒ๐ฟ and get ready to learn about our company's impact on the world of precision medicine from the inside! #medicine #precisionmedicine #radiology
